DIPG-35. A NOVEL HDAC INHIBITOR IN NEW PATIENT-DERIVED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) MODELS
Author(s) -
Matthew C. Biery,
Carrie Myers,
Emily J. Girard,
Shelli M. Morris,
Savanna S. Carmack,
Alyssa Noll,
Jay F. Sarthy,
Eric Ferguson,
Andrew J. Mhyre,
Andrew D. Strand,
James M. Olson,
Nicholas A. Vitanza
Publication year - 2018
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noy059.128
Subject(s) - panobinostat , medicine , cancer research , in vivo , glioma , bioluminescence imaging , oncology , pathology , cell culture , luciferase , biology , histone deacetylase , histone , gene , genetics , biochemistry , microbiology and biotechnology , transfection
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom